Page 98 - Annual Report
P. 98

HONG KONG ACADEMY OF MEDICINE
                   港
                           科
                     醫
                       學
                         專
                               院
                             學
                 香 香港醫學專科學院
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                 FOR THE YEAR ENDED 31 DECEMBER 2022




                 19.  FINANCIAL INSTRUMENTS (Continued)
                      d)   Currency risk

                          The  Group’s  functional  currency  is  Hong  Kong  dollars.  The  Group  is  exposed  to
                          currency risk through cash and bank balances denominated in Renminbi (“RMB”) and
                          United States dollars (“USD”). As the Hong Kong dollar (“HKD”) is pegged to the USD,
                          the Group does not expect any significant movements in the USD/HKD exchange rate.
                          At  31  December  2022,  it  is  estimated  that  a  general  increase  or  decrease  in  5%  of
                          exchange rates, with all variables held constant, would decrease/increase the Group’s
                          deficit for the year and increase/decrease the Group’s general fund by approximately
                          HK$15,000 (2021: HK$15,000).

                      e)   Fair values measurement

                          Fair value hierarchy

                          The following table presents the fair value of the Group’s financial instruments measured
                          at the end of the reporting period on a recurring basis, categorised into the three-level
                          fair value hierarchy as defined in HKFRS 13, Fair value measurement. The level into
                          which  a  fair  value  measurement  is  classified  is  determined  with  reference  to  the
                          observability and significance of the inputs used in the valuation technique as follows:

                          •    Level 1 valuations: Fair value measured using only Level 1 inputs i.e. unadjusted
                                quoted  prices  in  active  markets  for  identical  assets  or  liabilities  at  the
                                measurement date.

                          •    Level  2  valuations:  Fair  value  measured  using  Level  2  inputs  i.e.  observable
                                inputs which fail to meet Level 1, and not using significant unobservable inputs.
                                Unobservable inputs are inputs for which market data are not available.

                          •    Level 3 valuations: Fair value measured using significant unobservable inputs.

                                                     Fair value as at                Valuation     Significant
                                             31 December   31 December   Fair value   techniques and   unobservable
                          Financial assets         2022         2021   hierarchy     key inputs     inputs
                                                    HK$         HK$

                          Investments in equity
                            instruments
                            designated at
                            FVTOCI
                                                                                 Quoted bid prices
                          Listed equity securities     4,483,002      4,934,040     Level 1    in an active market     N/A

                          At 31 December 2022 and 2021, all financial instruments measured at fair value fall into
                          level 1 of the fair value hierarchy described above.










                                                           31


       96   HKAM Annual Report 2023
   93   94   95   96   97   98   99   100   101   102   103